Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01860911 · ClinicalTrials.gov registry record · Phase 1
Plasma Triglyceride Extraction by The Muscle
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT01860911: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01860911 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01860911, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
Increased accumulation of fat into the muscles is associated with what is called insulin-resistant state, which is a pre-diabetic state. The purpose of this research is to find out how fat circulating in the blood following fat consumption is taken up by the muscles in healthy people as well as people that are insulin-resistant. The investigators are specifically interested in how a hormone called insulin is involved in this process. Findings from this research will contribute to our understanding of why insulin-resistant people have increased accumulation of fat in their muscles, and ultimately help to design appropriate interventions to prevent type 2 Diabetes.
Interventions
- DRUG Insulin
- DRUG NG-monomethyl-L-arginine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01860911
The ClinicalTrials.gov registry entry for NCT01860911 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin is the first listed.
NCT01860911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01860911 about?
NCT01860911 is a clinical study titled "Plasma Triglyceride Extraction by The Muscle". Increased accumulation of fat into the muscles is associated with what is called insulin-resistant state, which is a pre-diabetic state. The purpose of this research is to find out how fat circulating in the blood following fat consumption is taken up by the muscles in healthy people as well as peop...
What is the current status of trial NCT01860911?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2013-04. Estimated completion is 2016-08-31.
What interventions are being tested in trial NCT01860911?
The interventions under investigation include: Insulin (DRUG), NG-monomethyl-L-arginine (DRUG).
Who is sponsoring clinical trial NCT01860911?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.